No one’s sure if synthetic mirror life will kill us all
Apr 29, 2026 - 24:56
Radio and PodcastLive Radio & PodcastsTechnology
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
A small group of volunteers will receive multiple injections of an experimental treatments for various enhancements . This story was written by Jessica Hamzelou and narrated by Noa - newsoveraudio.com
About This Episode
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” is an episode from In Machines We Trust by MIT Technology Review. A small group of volunteers will receive multiple injections of an...
Podcast
This episode belongs to In Machines We Trust.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 15, 2026, 14:13 long, audio available.
Related Episodes
Continue listening to more episodes from In Machines We Trust.
Desalination plants in the Middle East are increasingly vulnerable
Apr 22, 2026 - 10:46
The gig workers who are training humanoid robots at home
Apr 8, 2026 - 11:30
Can quantum computers now solve health care problems? We’ll soon find out.
Apr 1, 2026 - 13:09
How Pokémon Go is giving delivery robots an inch-perfect view of the world
Mar 25, 2026 - 10:46
How uncrewed narco subs could transform the Colombian drug trade
Mar 18, 2026 - 19:19
America was winning the race to find Martian life. Then China jumped in.
Mar 11, 2026 - 34:41
The curious case of the disappearing Lamborghinis
Mar 4, 2026 - 30:42
Questions About This Episode
What is This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” about?
A small group of volunteers will receive multiple injections of an experimental treatments for various enhancements . This story was written by Jessica Hamzelou and narrated by Noa - newsoveraudio.com
Where can I listen to This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”?
You can listen to This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” from?
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” is an episode from In Machines We Trust by MIT Technology Review.
How long is this episode?
This episode is 14:13 long.
When was this episode published?
This episode was published on Apr 15, 2026.
Can I save This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from In Machines We Trust?
Yes. This page shows related episodes from In Machines We Trust when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”?
You can listen to This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” is from In Machines We Trust by MIT Technology Review.
What are the episode details?
Published Apr 15, 2026 and 14:13 long